The study by Jin and his team [19] indicates that diabetic patients with arteriosclerosis, macrovascular, or microvascular undergo an increase in circulating FGF21 levels, especially in the early stage of atherosclerosis, and regards this increase as a compensatory upregulation, which is consistent with the results of this study. The gene discussed is FGF21; the disease is arteriosclerosis disorder.